NATH BIOGENES (INDIA)
Back to All Ratios
|
NATH BIOGENES (INDIA) Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 10.58 | 11.91 | 11.62 | -24.21 | 8.53 |
What is the latest Profit After Tax (PAT) Margin ratio of NATH BIOGENES (INDIA) ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 10.58 |
| Mar2024 | 11.91 |
| Mar2023 | 11.62 |
| Mar2022 | -24.21 |
| Mar2013 | 8.53 |
How is Profit After Tax (PAT) Margin of NATH BIOGENES (INDIA) Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 10.58 | -11.17 | |
| Mar2024 | 11.91 | 2.50 | |
| Mar2023 | 11.62 | Positive | |
| Mar2022 | -24.21 | Negative | |
| Mar2013 | 8.53 | - | |
Other Financial Ratios of NATH BIOGENES (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹305.9 Cr | 4.3% | 3.9% | -15.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,120.3 Cr | 2.8% | -0.2% | -11.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,010.9 Cr | 0.8% | -1% | 12% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,257.5 Cr | 6.3% | 16.9% | -14.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,123.6 Cr | 2.5% | 1.4% | -31.7% | Stock Analytics | |
| INDO US BIOTECH | ₹241.8 Cr | -2.2% | -8.6% | -64.3% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 4.3% |
3.9% |
-15.3% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses